M. Reindl

Body fluid markers for multiple sclerosis and differential diagnosis from atypical demyelinating disorders
20242 citationsauthor #3
Impaired Brain Growth in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Acute Disseminated Encephalomyelitis
20237 citationsauthor #16
Combining specific task-oriented training with manual therapy to improve balance and mobility in patients after stroke: a mixed methods pilot randomised controlled trial
20235 citationsauthor #4
Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5
20232 citationsauthor #6
MOG‐IgG‐Associated Bilateral Optic Neuritis in Temporal Relation to Monkeypox Vaccination
20231 citationsauthor #4
Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria.
2023786 citationsauthor #16
High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis
202314 citationsauthor #11
Factors influencing the willingness to adopt telerehabilitation among rehabilitation professionals in Austria and Germany: a survey comparing data before and during COVID-19
20239 citationsauthor #5
Serum MOG IgG titres should be performed routinely in the diagnosis and follow-up of MOGAD: Yes
20238 citationsauthor #1
Immune profiling in multiple sclerosis: a single-center study of 65 cytokines, chemokines, and related molecules in cerebrospinal fluid and serum
202315 citationsauthor #16
Blood–Brain Barrier Breakdown in Neuroinflammation: Current In Vitro Models
202349 citationsauthor #2
Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosis
20239 citationsauthor #9
Humoral signatures of MOG-antibody-associated disease track with age and disease activity
202327 citationsauthor #10
Salivary antibodies induced by BA.4/BA.5-convalescence or bivalent booster Immunoglobulin vaccination protect against novel SARS-COV-2 variants of concern
20232 citationsauthor #5
Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder
202221 citationsauthor #13
Inflammatory brain injury after severe viral infection is not unique to COVID-19
20220 citationsauthor #2
Salivary IgAs and Their Role in Mucosal Neutralization of SARS-CoV-2 Variants of Concern
20225 citationsauthor #5
Soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1) and Natalizumab Serum Concentration as Potential Biomarkers for Pharmacodynamics and Treatment Response of Patients with Multiple Sclerosis Receiving Natalizumab
20220 citationsauthor #11
Guilty by association? SARS-Cov2 antibodies and MOGAD.
20220 citationsauthor #2
MR imaging in children with transverse myelitis and acquired demyelinating syndromes.
20228 citationsauthor #13
More Efficient Complement Activation by Anti–Aquaporin-4 Compared With Anti–Myelin Oligodendrocyte Glycoprotein Antibodies
202228 citationsauthor #14
Guilty by association? SARS‐CoV‐2 antibodies and myelin oligodendrocyte glycoprotein antibody‐associated disease
20220 citationsauthor #2
Anti-NMDA receptor encephalitis and MOG-associated demyelination – a case report with long-term follow-up and a systematic review
20227 citationsauthor #8
Serum Neutralization Against SARS-CoV-2 Variants Is Heterogenic and Depends on Vaccination Regimen
20226 citationsauthor #4
Serum neurofilament light-chain levels in children with monophasic myelin oligodendrocyte glycoprotein-associated disease, multiple sclerosis, and other acquired demyelinating syndrome
202231 citationsauthor #8
The Potential Pathogenicity of Myelin Oligodendrocyte Glycoprotein Antibodies in the Optic Pathway
202213 citationsauthor #3
Comparative analyses of IgG/IgA neutralizing effects induced by three COVID-19 vaccines against variants of concern
202223 citationsauthor #4
Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF
202250 citationsauthor #27
Pathogenic autoantibodies in multiple sclerosis — from a simple idea to a complex concept
202242 citationsauthor #4
Peripheral neuropathy and MOG-IgG: A clinical and neuropathological retrospective study.
20227 citationsauthor #3
Factors and strategies affecting motor imagery ability in people with multiple sclerosis: a systematic review.
202214 citationsauthor #2
T-Cell Specificity Influences Disease Heterogeneity in Multiple Sclerosis
202129 citationsauthor #10
Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome
202156 citationsauthor #47
Antibodies to MOG in CSF only: pathological findings support the diagnostic value
202119 citationsauthor #11
Frequency of myelin oligodendrocyte glycoprotein antibodies in a large cohort of neurological patients
202140 citationsauthor #5
Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
20213 citationsauthor #13
Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?
202141 citationsauthor #12
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Varicella Zoster Virus Infection - Frequency of an Association
20218 citationsauthor #12
Invasive validation of a novel approach to determine aortic valve area with phase-contrast cardiac magnetic resonance imaging
20210 citationsauthor #3
Cardio-pulmonary transit-time by cardiac magnetic resonance imaging: associates to infarct severity and adverse events after reperfused STEMI
20211 citationsauthor #2
Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?
20210 citationsauthor #12
Complement Activation Is a Prominent Feature of MOGAD
202150 citationsauthor #7
Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases
202121 citationsauthor #29
German translation, cultural adaptation and validation of the unidimensional self-efficacy scale for multiple sclerosis
20213 citationsauthor #3
12-month SARS-CoV-2 antibody persistency in a Tyrolean COVID-19 cohort
20213 citationsauthor #8
Myelin-oligodendrocyte glycoprotein antibody-associated disease.
2021378 citationsauthor #29
Cardiac magnetic resonance derived global longitudinal strain outperforms established functional parameters in prognostication after ST-elevation myocardial infarction
20210 citationsauthor #2
Glycine Receptor Antibodies in Pediatric Patients with Facial Nerve Palsy
20210 citationsauthor #8
NfL levels predominantly increase at disease onset in MOG-Abs-associated disorders.
202128 citationsauthor #13
Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients
202144 citationsauthor #6
Evolution of myocardial tissue injury over a decade after ST-elevation myocardial infarction: a cardiac magnetic resonance study
20210 citationsauthor #3
Functional Recovery in Autoimmune Encephalitis: A Prospective Observational Study
20217 citationsauthor #22
Reply to “Investigating the Immunopathogenic Mechanisms Underlying MOGAD”
20215 citationsauthor #7
Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
202168 citationsauthor #13
Influence of myocardial damage on serum procalcitonin in ST-elevation myocardial infarction
20200 citationsauthor #1
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients.
2020155 citationsauthor #55
Are aquaporin antibody titers useful outcome measures for neuromyelitis optica spectrum disorders?
20207 citationsauthor #1
Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up
20205 citationsauthor #10
Transient MOG antibody seroconversion associated with immunomodulating therapy.
20205 citationsauthor #7
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
2020131 citationsauthor #26
Teaching NeuroImages: Bilateral optic neuritis
20200 citationsauthor #4
German Translation, Cultural Adaption and Validation of the Unidimensional Self-efficacy Scale for Multiple Sclerosis Using Rasch Analysis
20200 citationsauthor #3
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients
202064 citationsauthor #36
Diagnostic features of initial demyelinating events associated with serum MOG-IgG.
20202 citationsauthor #15
Antibodies to nodal/paranodal proteins in paediatric immune-mediated neuropathy
202023 citationsauthor #15
Presence of anti-neuronal antibodies in children with neurological disorders beyond encephalitis.
20203 citationsauthor #5
High association of MOG-IgG antibodies in children with bilateral optic neuritis.
202037 citationsauthor #25
Antibody signatures in patients with histopathologically defined multiple sclerosis patterns
202013 citationsauthor #4
Cardiac magnetic resonance derived global longitudinal strain outperfoms established functional parameters in prognostication after ST-elevation myocardial infarction
20200 citationsauthor #2
Recent developments in MOG-IgG associated neurological disorders
202054 citationsauthor #2
High-salt diet does not boost neuroinflammation and neurodegeneration in a model of α-synucleinopathy
202012 citationsauthor #3
Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies
202075 citationsauthor #18
6-month SARS-CoV-2 antibody persistency in a Tyrolian COVID-19 cohort
202014 citationsauthor #10
Induction of aquaporin 4-reactive antibodies in Lewis rats immunized with aquaporin 4 mimotopes
202010 citationsauthor #22
Epidemiology of Pediatric NMOSD in Germany and Austria
202015 citationsauthor #7
Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers.
202026 citationsauthor #10
Clinical risk score for prediction of early left ventricular thrombus after percutaneous coronary intervention for ST-elevation myocardial infarction
20200 citationsauthor #3
International multicenter examination of MOG antibody assays
2020230 citationsauthor #1
Cell-based assays for the detection of MOG antibodies: a comparative study
202063 citationsauthor #21
Self-navigated MRI 3D whole heart sequence for non-enhanced aortic root measurement in transcatheter aortic valve intervention: comparison to cardiac CT
20200 citationsauthor #6
MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis
202022 citationsauthor #5
Induction of aquaporin 4-reactive antibodies in Lewis rats immunized with aquaporin 4 mimotopes
20200 citationsauthor #22
Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases
202031 citationsauthor #10
Distinct serum and cerebrospinal fluid cytokine and chemokine profiles in autoantibody-associated demyelinating diseases
201925 citationsauthor #14
Loss of Neurological Disease HSAN-I-Associated Gene SPTLC2 Impairs CD8+ T Cell Responses to Infection by Inhibiting T Cell Metabolic Fitness.
201937 citationsauthor #12
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases
201992 citationsauthor #13
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders
201952 citationsauthor #29
Unfavorable Structural and Functional Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Optic Neuritis
201921 citationsauthor #7
German translation, cultural adaption and validation of the unidimensional self-efficacy scale for multiple sclerosis: a study protocol
20196 citationsauthor #3
Failure of Expected Brain Growth in Children with ADEM
20190 citationsauthor #10
P613Biomarker assessment for early infarct size estimation in ST-elevation myocardial infarction
20190 citationsauthor #2
P3095Left ventricular thrombus formation after ST-elevation myocardial infarction: a prospective observational CMR study
20190 citationsauthor #3
Tocilizumab treatment in severe recurrent anti-MOG-associated optic neuritis
201938 citationsauthor #2
53Impact of smoking on cardiac magnetic resonance infarct characteristics and clinical outcome in patients with non-ST-elevation myocardial infarction
20190 citationsauthor #9
4937Global longitudinal strain by feature tracking predicts adverse remodeling in ST-elevation myocardial infarction incremental to
20190 citationsauthor #2
Clinical Features and Outcomes of Pediatric Monophasic and Recurrent Idiopathic Optic Neuritis
20197 citationsauthor #7
Frequency of Spinal Cord Involvement and Autoantibody Status in a Large Cohort of Children Presenting with a First Acute Demyelinating Syndrome
20190 citationsauthor #13
Results of the ESPED Study “Neuromyelitis Optica Spectrum Disorders in Children and Adolescents
20190 citationsauthor #7
P1697Determinants and prognostic value of cardiac magnetic resonance imaging derived infarct characteristics in Non-ST-Elevation Myocardial Infarction
20190 citationsauthor #11
Change of olfactory function as a marker of inflammatory activity and disability progression in MS
201933 citationsauthor #10

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT